Oral lesions as predictors of highly active antiretroviral therapy failure in Brazilian HIV‐infected children
- 26 July 2007
- journal article
- Published by Wiley in Journal of Oral Pathology & Medicine
- Vol. 37 (2) , 99-106
- https://doi.org/10.1111/j.1600-0714.2007.00598.x
Abstract
Objectives: Evaluate the accuracy of HIV‐related oral lesions to predict immune and virologic failure on HIV‐infected children in use of highly active antiretroviral therapy (HAART). Study design: Data for this cross‐sectional analysis come from a longitudinal study being conducted through the HIV‐AIDS Outpatient Unit, ENT Division, Hospital das Clinicas, Sao Paulo University Medical School. The study began in January 1990 and is still ongoing. The cut‐off point for analyses purposes was December 2004. Subjects were 471 HIV‐infected consecutive children attending the outpatient unit during this period, who enrolled regardless of medical or immunological status. The children have undertaken oral cavity examination, serum CD4+ T‐lymphocyte count, and, 271 of them, viral load measurement. Sensitivity, specificity, positive predictive value, negative predictive value and relative risk were calculated. Results: Oral lesions had moderate sensitivity, high specificity and positive predictive value to predict immune failure. It had low sensitivity and positive predictive value, and high specificity to predict virologic failure. Discussion and conclusions: Oral manifestations of HIV can be important markers for immune suppression and for virologic failure, in Brazilian children undergoing HAART.Keywords
This publication has 32 references indexed in Scilit:
- Oral Candidosis as a Clinical Marker of Immune Failure in Patients with HIV/AIDS on HAARTAIDS Patient Care and STDs, 2005
- Effect of PI‐HAART on the prevalence of oral lesions in HIV‐1 infected patients. A Greek studyOral Diseases, 2004
- Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected childrenThe Pediatric Infectious Disease Journal, 2003
- Prevalence of Oral Lesions in Mexican Children with Perinatally Acquired HIV: Association with Immunologic Status, Viral Load, and GenderAIDS Patient Care and STDs, 2002
- Oral Lesions in HIV/AIDS Patients Undergoing Highly Active Antiretroviral Treatment Including Protease Inhibitors: A New Face of Oral AIDS?AIDS Patient Care and STDs, 2000
- Decline in the rate of oral opportunistic infections following introduction of highly active antiretroviral therapyJournal of Oral Pathology & Medicine, 2000
- Impact of protease inhibitor therapy on HIV-related oropharyngeal candidiasisAIDS, 2000
- Oral manifestations of HIV infection by gender and transmission category in Mexico CityJournal of Oral Pathology & Medicine, 1998
- Epidemiology, clinical features and prognostic value of HIV-1 related oral lesionsJournal of Oral Pathology & Medicine, 1990